The U.S. Food and Drug Administration (FDA) on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.The agency approved Lyfgenia from bluebird bio, and a separate treatment… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
IntroductionProgressive supranuclear palsy (PSP) is a neurodegenerative brain disease that affects patient’s functionality and quality of life. Physiotherapy should be recommended at the time of diagnosis to slow the progression of disability and enhance the quality of life of these patients.Clinical presentationHere, we describe three cases of patients with PSP, outlining their motor and non-motor […]
In a new study of more than 50,000 Korean adolescents, those who used a smartphone for more than 4 hours per day had higher rates of adverse mental health and substance use. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.